Stockwinners Market Radar for April 29, 2018 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
AMT... | Hot Stocks20:17 EDT American Tower releases information regarding business with Sprint, T-Mobile - American Tower Corporation (AMT) released information about its business in light of the proposed merger between Sprint (S) and T-Mobile US (TMUS) for the quarter ended December 31, 2017, Sprint and T-Mobile US each accounted for approximately 8% of American Tower's consolidated property revenues. For the quarter ended December 31, 2017, on sites where both companies had separate leases for antenna space, the revenue generated from Sprint represented approximately 4% of American Tower's consolidated property revenues and the revenue generated from T-Mobile US represented approximately 3% of American Tower's consolidated property revenues. The average remaining non-cancellable current lease term on these sites with Sprint and T-Mobile US is approximately three to four years. American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 160,000 communications sites.
|
DIS... | Hot Stocks19:36 EDT On The Fly: Top five weekend stock stories - Catch up on the weekend's top five stories with this list compiled by The Fly: 1. T-Mobile (TMUS) and Sprint (S) announced they have entered into a definitive agreement to merge in an all-stock transaction at a fixed exchange ratio of 0.10256 T-Mobile shares for each Sprint share or the equivalent of 9.75 Sprint shares for each T-Mobile US share. Based on closing share prices on April 27, this represents a total implied enterprise value of approximately $59B for Sprint and approximately $146B for the combined company. 2. Prologis (PLD) and DCT Industrial Trust (DCT) announced that the two companies have entered into a definitive merger agreement by which Prologis will acquire DCT for $8.4B in a stock-for-stock transaction, including the assumption of debt. The boards of directors of both companies have unanimously approved the transaction. 3. Any week now, Netflix (NFLX) will surpass in market value Walt Disney (DIS) as investors cheer on the streaming service's continued subscriber growth, Jack Hough wrote in this week's edition of Barron's. Investors who buy Disney shares now could have a long wait before they learn whether the streaming push will result in a rebounding price/earnings ratio, but that is where a diversified business model helps, Hough noted. 4. Disney and Marvel's "Avengers: Infinity War" opened to a record-setting $250M in North America and $380M overseas for a global total of $630M, the top worldwide debut of all time. The movie is the first to be shot entirely with Imax cameras, with Imax (IMAX) theaters delivering $41M of the total worldwide gross. "Avengers: Infinity War" earned a A CinemaScore and sports an 86% Rotten Tomatoes score. 5. Ensco (ESV) saw a positive mention in Barron's, while Chipotle Mexican Grill (CMG) was mentioned cautiously.
|
BIDU CG | Hot Stocks18:34 EDT Baidu enters into definitive agreements to divest financial services business - Baidu (BIDU) announced that it has entered into definitive agreements with certain investors relating to the divestiture of its financial service business, or Financial Services Group, which provides consumer credit, wealth management and other financial services. The investors are led by TPG and The Carlyle Group (CG), with participation from Taikang Group, ABC International Holdings and others. Pursuant to the definitive agreements, Baidu will divest a majority equity stake in FSG, which has been renamed as Du Xiaoman Financial. Through the transaction, Du Xiaoman will raise approximately $1.9B, among which Du Xiaoman will receive $840M with the remaining balance used to purchase existing stake. Upon the completion of the transaction, Baidu will own approximately 42% of Du Xiaoman's outstanding shares and will no longer have effective control over Du Xiaoman. Du Xiaoman will operate independently from Baidu and will enter into business cooperation arrangements with Baidu. Guang Zhu, Baidu Senior Vice President and General Manager of FSG, will become CEO of Du Xiaoman. The transactions contemplated under the definitive agreements are subject to certain closing conditions and are currently expected to close in the second half of 2018. Upon the completion of the transactions, it is expected that Du Xiaoman will be deconsolidated from Baidu's consolidated financial statements.
|
DCT | Hot Stocks16:20 EDT DCT Industrial declares 36c per share quarterly cash dividend - Payable on July 11, 2018 to stockholders of record as of June 29, 2018.
|
PLD DCT | Hot Stocks15:52 EDT Prologis to acquire DCT Industrial Trust for $8.4B - Prologis (PLD) and DCT Industrial Trust (DCT) announced that the two companies have entered into a definitive merger agreement by which Prologis will acquire DCT for $8.4B in a stock-for-stock transaction, including the assumption of debt. The boards of directors of both companies have unanimously approved the transaction. The transaction is anticipated to create substantial synergies, including near-term synergies of approximately $80M in corporate general and administrative cost savings, operating leverage, interest expense and lease adjustments, which are forecast to increase annual stabilized core funds from operations per share by 6c-8c. A combination of revenue synergies and incremental development volume has the potential to generate $40M of additional annual revenue and development profit in the future. Under the terms of the agreement, DCT shareholders will receive 1.02 Prologis shares for each DCT share they own. The transaction, which is currently expected to close in the third quarter of 2018, is subject to the approval of DCT stockholders and other customary closing conditions. At closing, it is anticipated that Philip L. Hawkins will join the Prologis board of directors.
|
TWX... | Hot Stocks15:19 EDT Box Office Battle: 'Avengers: Infinity War' wins weekend with record $250M - Disney (DIS) and Marvel's "Avengers: Infinity War" opened to a record-setting $250M in North America and $380M overseas for a global total of $630M, the top worldwide debut of all time. The movie is the first to be shot entirely with Imax cameras, with Imax (IMAX) theaters delivering $41M of the total worldwide gross. "Avengers: Infinity War" earned a A CinemaScore and sports an 86% Rotten Tomatoes score. BOX OFFICE RUNNERS-UP: Paramount's (VIAB) horror sensation "A Quiet Place" came in second, earning $10.7M for a domestic total of $148.2M. Behind it was STX Entertainment's "I Feel Pretty," with an estimated $8.1M for a $29.6M total. Warner Bros.' (TWX) New Line movie "Rampage" place number four, falling 65% to $7.1M for a domestic cume of $77.9M at the end of its third weekend. Rounding out the top five, Disney and Marvel Studios' "Black Panther" once again spiked, earning $4.4M in its 11th weekend. Other publicly traded companies in filmmaking include 21st Century Fox's (FOXA; FOX), Comcast (CMCSA, CMCSK), Lionsgate's (LGF.A), and Sony's (SNE).
|
ON | Hot Stocks14:51 EDT ON Semiconductor CEO sees 'upwards inflection in long-term demand' - "We delivered strong revenue and margin performance in the first quarter. We are seeing an upwards inflection in long-term demand for our products, driven by strengthening engagement with our customers on their long-term strategic projects and broad-based acceptance of our products for automotive and industrial markets," said Keith Jackson, president and CEO of ON Semiconductor. "Along with robust revenue performance, we continue to deliver impressive margin performance driven by solid execution, improving mix, and operating leverage. We continue to make strong progress towards our target financial model." "Sustained demand has put pressure on the semiconductor industry's supply chain. We are pro-actively investing in our operations to further strengthen our industry leading cost structure and to ensure supply for our customers."
|
S TMUS | Hot Stocks14:40 EDT T-Mobile, Spring enter definitive agreement to merger in all-stock transaction - T-Mobile US (TMUS) and Sprint (S) announced they have entered into a definitive agreement to merge in an all-stock transaction at a fixed exchange ratio of 0.10256 T-Mobile shares for each Sprint share or the equivalent of 9.75 Sprint shares for each T-Mobile US share. Based on closing share prices on April 27, this represents a total implied enterprise value of approximately $59B for Sprint and approximately $146B for the combined company. The combined company will be named T-Mobile and will be headquartered in Bellevue, Wash., with a second headquarters in Overland Park, Kan. John Legere, current President and Chief Executive Officer of T-Mobile US and the creator of T-Mobile's successful Un-carrier strategy, will serve as Chief Executive Officer, and Mike Sievert, current Chief Operating Officer of T-Mobile, will serve as President and Chief Operating Officer of the combined company. The remaining members of the new management team will be selected from both companies during the closing period. Tim Hottges, current T-Mobile US Chairman of the Board, will serve as Chairman of the Board for the new company. Masayoshi Son, current SoftBank Group Chairman and CEO, and Marcelo Claure, current Chief Executive Officer of Sprint, will serve on the board of the new company. "This combination will create a fierce competitor with the network scale to deliver more for consumers and businesses in the form of lower prices, more innovation, and a second-to-none network experience - and do it all so much faster than either company could on its own," said John Legere. "As industry lines blur and we enter the 5G era, consumers and businesses need a company with the disruptive culture and capabilities to force positive change on their behalf." "The combination of these two dynamic companies can only benefit the U.S. consumer. Both Sprint and T-Mobile have similar DNA and have eliminated confusing rate plans, converging into one rate plan: Unlimited," said Marcelo Claure. "We intend to bring this same competitive disruption as we look to build the world's best 5G network that will make the U.S. a hotbed for innovation and will redefine the way consumers live and work across the U.S., including in rural America. As we do this, we will force our competitors to follow suit, as they always do, which will benefit the entire country. I am confident this combination will spur job creation and ensure opportunities for Sprint employees as part of a larger, stronger combined organization, and I am thrilled that Kansas City will be a second headquarters for the merged company."
|
FLXN | Hot Stocks10:27 EDT Flexion announces presentation of positive FX201 data - Flexion Therapeutics announced the presentation of positive preclinical data supporting the FX201 program at the Osteoarthritis Research Society International 2018 World Congress, April 26-29, Liverpool, U.K. In December 2017, Flexion acquired the global rights to GQ-203 for human applications, now known as FX201, from GeneQuine Biotherapeutics GmbH and obtained an exclusive license to the underlying intellectual property rights to the program from Baylor College of Medicine in Houston, Texas. FX201 is an intra-articular gene therapy candidate designed to induce the production of human interleukin-1 receptor antagonist whenever inflammation is present within the joint. Based on strong preclinical data, a single injection of FX201 could potentially enable expression of IL-1Ra in an osteoarthritic joint for a least one year. By controlling chronic inflammation for extended periods of time, Flexion believes FX201 holds the potential to both reduce OA pain and modify disease. "These data strongly support the continued evaluation of FX201 as a novel, non-opioid approach that may provide long-term pain relief and modify disease in patients confronting progressive OA," said Michael Clayman, President and CEO. "This presentation bolsters our excitement about advancing the development of FX201, and we look forward to achieving our goal of initiating first in human clinical trials in 2019."
|